AstraZeneca

AstraZeneca launches global R&D Postdoctoral Challenge to accelerate scientific discovery and diversity

AstraZeneca has launched a global R&D Postdoctoral Challenge to help accelerate ideas to transform the treatment of some of the world’s most complex diseases. The challenge, launched at EXPO 2020 Dubai, invites final year MD and/or PhD students and postdoctoral researchers from across the world to propose their innovative ideas to help accelerate drug discovery…

Read More
COVID-19 Vaccine AstraZeneca

COVID-19 Vaccine AstraZeneca significantly boosted antibody levels against Omicron

University of Oxford study supports use of COVID-19 Vaccine AstraZeneca as third dose booster against Omicron Neutralising antibody levels against Omicron following a third dose boost of COVID-19 Vaccine AstraZeneca were broadly similar to levels achieved after two doses against the Delta variant. AstraZeneca’s Vaxzevria (ChAdOx1-S [Recombinant]) significantly boosted levels of antibodies against the Omicron…

Read More